J.W. Cole Advisors Inc. Has $7.24 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

J.W. Cole Advisors Inc. increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 15.2% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 13,821 shares of the healthcare conglomerate's stock after buying an additional 1,820 shares during the period. J.W. Cole Advisors Inc.'s holdings in UnitedHealth Group were worth $7,239,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group during the 4th quarter worth approximately $26,000. Hurley Capital LLC bought a new position in UnitedHealth Group during the fourth quarter worth $28,000. Aster Capital Management DIFC Ltd bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $30,000. Kapitalo Investimentos Ltda bought a new stake in UnitedHealth Group during the fourth quarter worth about $41,000. Finally, Copia Wealth Management bought a new stake in UnitedHealth Group during the fourth quarter worth about $42,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Up 0.9%

Shares of UNH stock traded up $2.63 during mid-day trading on Wednesday, hitting $287.76. The stock had a trading volume of 6,136,377 shares, compared to its average volume of 7,869,486. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. The firm has a market capitalization of $261.04 billion, a P/E ratio of 12.05, a price-to-earnings-growth ratio of 1.38 and a beta of 0.45. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73. The firm's 50-day moving average is $304.47 and its two-hundred day moving average is $432.39.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were given a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 3.07%. The ex-dividend date was Monday, June 16th. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio (DPR) is 37.02%.

Wall Street Analysts Forecast Growth

UNH has been the topic of several recent analyst reports. Piper Sandler dropped their price objective on UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating on the stock in a research note on Tuesday, June 3rd. JPMorgan Chase & Co. lifted their target price on UnitedHealth Group from $405.00 to $418.00 and gave the company an "overweight" rating in a report on Friday, June 20th. Baird R W downgraded UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, June 11th. Raymond James Financial downgraded UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research report on Wednesday, May 14th. Finally, Wall Street Zen downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $394.43.

Insiders Place Their Bets

In related news, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer directly owned 10,398 shares of the company's stock, valued at $3,171,390. The trade was a 5.36% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the firm's stock in a transaction on Wednesday, May 14th. The shares were bought at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the transaction, the director directly owned 6,033 shares in the company, valued at $1,935,386.40. This trade represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders have bought 109,408 shares of company stock valued at $31,607,768. 0.28% of the stock is owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.